BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28060381)

  • 1. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases.
    Bayón Y; Trinidad AG; de la Puerta ML; Del Carmen Rodríguez M; Bogetz J; Rojas A; De Pereda JM; Rahmouni S; Williams S; Matsuzawa S; Reed JC; Crespo MS; Mustelin T; Alonso A
    FEBS J; 2008 Aug; 275(15):3900-10. PubMed ID: 18573101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.
    Jin X; Jeon HM; Jin X; Kim EJ; Yin J; Jeon HY; Sohn YW; Oh SY; Kim JK; Kim SH; Jung JE; Kwak S; Tang KF; Xu Y; Rich JN; Kim H
    Cell Rep; 2016 Aug; 16(6):1629-1641. PubMed ID: 27477274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
    Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
    Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights into KCTD Protein Assembly and Cullin3 Recognition.
    Ji AX; Chu A; Nielsen TK; Benlekbir S; Rubinstein JL; Privé GG
    J Mol Biol; 2016 Jan; 428(1):92-107. PubMed ID: 26334369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
    Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
    Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc is required for maintenance of glioma cancer stem cells.
    Wang J; Wang H; Li Z; Wu Q; Lathia JD; McLendon RE; Hjelmeland AB; Rich JN
    PLoS One; 2008; 3(11):e3769. PubMed ID: 19020659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
    Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
    Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
    Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
    Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
    Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
    Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.
    Fang X; Zhou W; Wu Q; Huang Z; Shi Y; Yang K; Chen C; Xie Q; Mack SC; Wang X; Carcaboso AM; Sloan AE; Ouyang G; McLendon RE; Bian XW; Rich JN; Bao S
    J Exp Med; 2017 Jan; 214(1):245-267. PubMed ID: 27923907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Multisubunit E3 Ubiquitin Ligase Required for Heterotrimeric G-Protein β-Subunit Ubiquitination and Downstream Signaling.
    Young BD; Sha J; Vashisht AA; Wohlschlegel JA
    J Proteome Res; 2021 Sep; 20(9):4318-4330. PubMed ID: 34342229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
    Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
    Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition of Cullin3 by KCTDs: insights from experimental and computational investigations.
    Balasco N; Pirone L; Smaldone G; Di Gaetano S; Esposito L; Pedone EM; Vitagliano L
    Biochim Biophys Acta; 2014 Jul; 1844(7):1289-98. PubMed ID: 24747150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.